Covaxin trials between 2 – 18 years age group to commence within 10-12 days: Dr VK Paul
NITI Aayog member (health), Dr VK Paul declared on Tuesday that Bharat Biotech will be commencing with the phase II and phase III clinical trials for Covid-19 vaccine Covaxin among the children in the age group from 2 to 18 years within the next 10 -12 days. Amid a press conference Paul said, “Covaxin has…